		Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		DISTANT.METASTASIS		LYMPH.NODE.METASTASIS		TUMOR.STAGECODE		NEOPLASM.DISEASESTAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q
IL32	4 (4%)	97	9.4369e-15	2.26e-13	0.36596	1	0.30035	1	NA	NA	0.21722	1	0.62021	1	NA	NA	0.66668	1
CDC27	4 (4%)	97	0.59803	1	0.78002	1	0.59494	1	NA	NA	0.12973	1	0.15293	1	NA	NA	0.34477	1
NF2	7 (7%)	94	0.59803	1	0.29995	1	1	1	NA	NA	0.034708	0.798	0.074972	1	NA	NA	0.16224	1
SFRS2IP	5 (5%)	96	0.22626	1	0.12113	1	0.66071	1	NA	NA	0.082021	1	0.38507	1	NA	NA	0.31589	1
